Hjem › Brystkreft › Kansas › Kansas City
Kliniske studier for Brystkreft i Kansas City, KS
12 studier for Brystkreft søker deltakere på steder i og rundt Kansas City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi unna
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- AMR Kansas City Oncology, Kansas City
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- University of Kansas Cancer Center, Kansas City
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- KCCC West, Kansas City
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruttererFase 3
- University of Kansas Cancer Center, Kansas City
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- University of Kansas Cancer Center, Kansas City
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
RekruttererFase 2
- University of Kansas Cancer Center, Kansas City
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
RekruttererFase 2
- University of Kansas Cancer Center, Kansas City
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
RekruttererFase 2
- The University of Kansas Cancer Center - Westwood, Kansas City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- University of Kansas Cancer Center, Kansas City
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of Kansas Medical Center, Kansas City
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruttererFase 3
- University of Kansas Cancer Center-West, Kansas City
- University of Kansas Cancer Center, Kansas City
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Kansas City
- Kardiovaskulær sykdom14 studier
- Hjertesvikt13 studier
- Fedme13 studier
- Interstitielle lungesykdommer13 studier
- Cystisk fibrose13 studier
- Blærekreft12 studier
- Akut myelogen leukemi12 studier
- Prostatakreft12 studier
- Ikke-småcellet lungekreft11 studier
- Lungekreft11 studier
- KOLS9 studier
- Astma8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.